Portfolio Management
We act like a Compass in directing you to the Right Portfolio.
Evaluations & Recommendations based on very comprehensive and all-encompassing parameters – Commercial, Preliminary IP, Clinical Studies Review, BE requirements, Forecasts, along with Business Case and Strategy.
Tailor-made Evaluations for you at –
- Therapy Level
- Product Level
- Volume based
- Competition based
- NCE (New Chemical Entities)
- Need-based
Pavani JSL’s experience in handling Portfolio roles of the Indian market in Dr.Reddy’s, Emerging Markets in Mylan & Global markets in Corporates like Aurobindo and Hetero ensures a Realistic Assessment with the right balance of Business Judgement and Futuristic Strategy for the management.
Portfolio Evaluations in Corporates
- 300+ Products identified in Corporates
- 100 products harmonized across 100 markets.
- Identified NCE’s,FTF, 505 (b)2’s, Day 181 & New Therapies identification
- Evaluated OSD, PFOS, Liquids, Softgels, Injections, Topicals, Penems, Peptides, Contrasting agents, patches……..
Projects Completed & Ongoing
- Completed 35 products evaluation along with Business case and Strategic recommendation US based organisation.
- Completed Derma, Low competition products, PFOS products analysis for 2 companies for US market
- Completed a unique New Formulation Evaluation and Entry Strategy for a German Company
- Enabling Portfolio strategy and pipeline for an Intermediates & API company for US, 5 EU, Key ROW markets
- Tied up with a US company for laying out a roadmap for Injectables.
- Provide Daily Generic Approvals Subscription service
- Provide expert consultations to venture capitalists
Testimonials
“For an introductory discussion, contact today:”
Pavani Consultancy Services is a Professional and Ethical Facilitator for Portfolio and Business Development in Pharmaceutical space.